or Try an Advanced Search...

    Adoptive Cell Transfer Stocks List

    Symbol Grade Name % Change
    CLLS C Cellectis S.A. 2.36
    IMTX C Immatics N.V. 5.45
    IOVA D Iovance Biotherapeutics, Inc. -1.47
    ADAP D Adaptimmune Therapeutics plc -1.71
    ALLO F Allogene Therapeutics, Inc. 2.07
    ACET F Adicet Bio, Inc. -7.64
    CERO F CERo Therapeutics Holdings, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Other
    Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma

    Related ETFs - A few ETFs which own one or more of the above listed Adoptive Cell Transfer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.27
    IDNA B iShares Genomics Immunology and Healthcare ETF 3.32
    WDNA C WisdomTree BioRevolution Fund 3.32
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 3.07
    MOON D Direxion Moonshot Innovators ETF 2.65
    View all Adoptive Cell Transfer ETFs...
    Compare ETFs
    Compare BBC to MOON Compare CNCR to BBC Compare CNCR to WDNA

        Adoptive Cell Transfer Stocks Recent News

        Date Stock Title
        May 14 ADAP Adaptimmune Q1 2024 Earnings Preview
        May 14 ACET Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
        May 14 IMTX Immatics reports Q1 results
        May 14 IMTX Immatics Announces First Quarter 2024 Financial Results and Business Update
        May 14 ALLO Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
        May 13 ALLO Allogene Therapeutics, Inc. (ALLO) Q1 2024 Earnings Call Transcript
        May 13 ALLO Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
        May 13 ALLO Allogene Therapeutics announces pricing of $110M offering of common stock
        May 13 ALLO Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
        May 13 ALLO Allogene Therapeutics GAAP EPS of -$0.38 beats by $0.03
        May 13 ALLO Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
        May 13 IOVA Iovance Biotherapeutics' Amtagvi: Innovative Therapy, Financial Strain (Rating Downgrade)
        May 12 ALLO Allogene Therapeutics Q1 2024 Earnings Preview
        May 10 IOVA Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi
        May 10 IOVA Why Iovance Stock Is Down 18% Today
        May 10 IOVA Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
        May 10 IOVA Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
        May 10 IOVA Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
        May 10 IOVA Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
        May 10 ALLO CollPlant Biotechnologies (CLGN) Soars 8.2%: Is Further Upside Left in the Stock?
        Related Industries: Biotechnology Other
        Related Stock Lists: Cancer Medicine Biopharmaceutical Cancer Immunotherapy Cell Therapy Clinical Medicine Immune System Immunotherapy Solid Tumors Biotechnology Cancer Treatment Tumors Of The Hematopoietic And Lymphoid Tissues Virotherapy Breast And Lung Cancer Cancer Immunotherapy Product Chimeric Antigen Receptor Hematological Malignancies Immunotherapy Products Melanoma Multiple Myeloma
        Adoptive Cell Transfer

        Adoptive cell transfer (ACT) is a type of immunotherapy that involves taking immune cells from a patient, modifying them in the laboratory, and then infusing them back into the patient to help fight cancer. ACT works by boosting the patient’s own immune system to recognize and attack cancer cells. It is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia.

        Browse All Tags